The popularity of Viagra initially fueled a period of growth for pharma, nevertheless recent shifts present a complicated scenario for those considering a stake. Generic competitors are reducing earnings, and https://dawudagif452365.topbloghub.com/47753390/the-blue-pill-and-big-pharma-a-precarious-play